How to Address Stability Testing for Breakthrough Therapy Drugs under FDA Guidelines
How to Address Stability Testing for Breakthrough Therapy Drugs under FDA Guidelines Stability Testing for Breakthrough Therapy Drugs: Navigating FDA Requirements Introduction Breakthrough therapy drugs are designated by the FDA for expedited development and review due to their potential to provide substantial improvement over existing therapies for serious conditions. These drugs require specific stability testing…
Read More “How to Address Stability Testing for Breakthrough Therapy Drugs under FDA Guidelines” »